Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Ethics in Research01:56

Ethics in Research

24.9K
Today, scientists agree that good research is ethical in nature and is guided by a basic respect for human dignity and safety. However, this has not always been the case. Modern researchers must demonstrate that the research they perform is ethically sound.
24.9K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

204
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
204
Regression Toward the Mean01:52

Regression Toward the Mean

6.6K
Regression toward the mean (“RTM”) is a phenomenon in which extremely high or low values—for example, and individual’s blood pressure at a particular moment—appear closer to a group’s average upon remeasuring. Although this statistical peculiarity is the result of random error and chance, it has been problematic across various medical, scientific, financial and psychological applications. In particular, RTM, if not taken into account, can interfere when...
6.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ethical complexities in contraceptive mandates for adolescent clinical trial participation: a qualitative analysis of U.S. adolescents' perspectives.

BMC medical ethics·2026
Same author

Ethical Challenges in the Delivery of Family-Centered Nursing Care.

Journal of family nursing·2026
Same author

Risk-calibrated sharing of human brain data.

Brain : a journal of neurology·2026
Same author

Training for complexity: Fostering interdisciplinary thinking in One Health graduate education.

One health (Amsterdam, Netherlands)·2026
Same author

Exome sequencing directly implicates 68 genes in inflammatory bowel disease.

medRxiv : the preprint server for health sciences·2026
Same author

The next phase in Long COVID research: addressing the ethical challenges in trials of disease-modifying treatments.

EClinicalMedicine·2026

Related Experiment Video

Updated: Oct 21, 2025

A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting
14:43

A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting

Published on: January 12, 2018

12.2K

IRB Decision-Making about Minimal Risk Research with Pregnant Participants.

Amina White1, Christine Grady2, Margaret Little3

  • 1Clinical associate professor in the Department of Obstetrics & Gynecology at the University of North Carolina at Chapel Hill.

Ethics & Human Research
|September 8, 2021
PubMed
Summary

Pregnant individuals are often excluded from research. Institutional Review Boards (IRBs) show varied interpretations of "minimal risk," impacting decisions on including pregnant participants in studies.

Keywords:
IRBclinical trialshuman research ethicsinstitutional review boardminimal risk researchresearch with pregnant personsresearch with pregnant women

More Related Videos

Working with Human Tissues for Translational Cancer Research
07:48

Working with Human Tissues for Translational Cancer Research

Published on: November 26, 2015

10.1K
Generating a Reproducible Model of Mid-Gestational Maternal Immune Activation using PolyI:C to Study Susceptibility and Resilience in Offspring
09:09

Generating a Reproducible Model of Mid-Gestational Maternal Immune Activation using PolyI:C to Study Susceptibility and Resilience in Offspring

Published on: August 17, 2022

1.9K

Related Experiment Videos

Last Updated: Oct 21, 2025

A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting
14:43

A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting

Published on: January 12, 2018

12.2K
Working with Human Tissues for Translational Cancer Research
07:48

Working with Human Tissues for Translational Cancer Research

Published on: November 26, 2015

10.1K
Generating a Reproducible Model of Mid-Gestational Maternal Immune Activation using PolyI:C to Study Susceptibility and Resilience in Offspring
09:09

Generating a Reproducible Model of Mid-Gestational Maternal Immune Activation using PolyI:C to Study Susceptibility and Resilience in Offspring

Published on: August 17, 2022

1.9K

Area of Science:

  • Medical research ethics
  • Regulatory science
  • Inclusion of vulnerable populations

Background:

  • Pregnant individuals are frequently excluded from clinical research, even for minimal-risk studies.
  • Lack of understanding exists regarding Institutional Review Board (IRB) decision-making processes for research involving pregnant participants.
  • Regulatory frameworks for research involving pregnant individuals require clearer interpretation and application.

Purpose of the Study:

  • To investigate Institutional Review Board (IRB) personnel's understanding of "minimal risk."
  • To identify factors influencing IRB decisions on research involving pregnant participants.
  • To assess variations in risk perception and approval willingness among IRB members.

Main Methods:

  • Survey of current and former IRB personnel in the United States.
  • Elicitation of interpretations of the "minimal risk" regulatory category.
  • Analysis of factors influencing approval/disapproval of research involving pregnant participants.

Main Results:

  • Some consensus exists among IRB members regarding the risk level of specific research procedures and hypothetical scenarios.
  • Significant variations were found in how IRB members assess risk and their willingness to approve minimal-risk research including pregnant women.
  • Discrepancies in risk characterization and regulatory application were identified.

Conclusions:

  • Guidance is necessary for IRB members to accurately characterize risk for research involving pregnant individuals.
  • Clearer application of federal regulations is needed to ensure appropriate inclusion or justified exclusion of pregnant people in research.
  • Standardized approaches to IRB decision-making can improve ethical research practices and participant inclusion.